-
Mashup Score: 4Home Page: JHLT Open - 27 day(s) ago
An Official Publication of the International Society for Heart and Lung Transplantation, JHLT Open brings readers essential scholarly and timely information in the field of cardiopulmonary transplantation, mechanical and biological support of the failing heart, advanced lung disease (including pulmonary vascular disease) and cell replacement therapy. Importantly, the journal also serves as a medium of communication of pre-clinical sciences in all these rapidly expanding areas. As a fully online and Gold
Source: www.jhltopen.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 17
Patient selection for real-world use of HeartMate 3 left ventricular assist device (HM3 LVAD) differs from that of clinical trials. We assessed adverse-event rates between “nontrial like” (NTL) and “trial like” (TL) patients who underwent commercial HM3 implantation.
Source: www.jhltopen.orgCategories: General Medicine News, CardiologistsTweet-
@RyanTedfordMD @HeartOTXHeartMD @MUSChealth @Jgrewal_12 @TheJHLT @PalakShahMD @manreetkanwar @AHajduczok @fsheikh22 @IRajapreyar @YevgeniyBr @Brian_Houston12 @HajjJennifer @mikerofael Great multicenter collaboration @RyanTedfordMD @Jgrewal_12 , consistent results seen with our center’s experience re: TL and NTL @VQChau20 @lacoyle78 https://t.co/egSOIhvTq8
-
-
Mashup Score: 1Home Page: JHLT Open - 7 month(s) ago
An Official Publication of the International Society for Heart and Lung Transplantation, JHLT Open brings readers essential scholarly and timely information in the field of cardiopulmonary transplantation, mechanical and biological support of the failing heart, advanced lung disease (including pulmonary vascular disease) and cell replacement therapy. Importantly, the journal also serves as a medium of communication of pre-clinical sciences in all these rapidly expanding areas. As a fully online and Gold
Source: www.jhltopen.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Have you checked out the latest science featured in #JHLTOpen? 🔖 Read now at 🔗https://t.co/Q7BHYO1zzP The journal is waiving all Article Processing Charges for all manuscripts submitted through 31 December, 2023. 📆 Submit by the end of the year at 🔗https://t.co/0bcELxEMZp https://t.co/hdnP5XIwsS
-
Have you checked out the latest science featured in #JHLTOpen? 🔖 Read now at 🔗https://t.co/Q7BHYO1zzP The journal is waiving all Article Processing Charges for all manuscripts submitted through 31 December, 2023. 📆 Submit by the end of the year at 🔗https://t.co/0bcELxEMZp https://t.co/hdnP5XIwsS